Cargando…
Global regulatory reforms to promote equitable vaccine access in the next pandemic
There is broad consensus that the global response to the Covid-19 pandemic was inadequate, leading to unacceptable levels of avoidable morbidity and mortality. Three strategic missteps led to the lack of equitable vaccine access: The heavy reliance on commercial vaccine manufacturers in high-income...
Autores principales: | Mahoney, Richard, Hotez, Peter J., Bottazzi, Maria Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584090/ https://www.ncbi.nlm.nih.gov/pubmed/37851688 http://dx.doi.org/10.1371/journal.pgph.0002482 |
Ejemplares similares
-
Developing a low-cost and accessible COVID-19 vaccine for global health
por: Hotez, Peter J., et al.
Publicado: (2020) -
Human Schistosomiasis Vaccines as Next Generation Control Tools
por: Hotez, Peter J., et al.
Publicado: (2023) -
The Race for Global Equitable Access to COVID-19 Vaccines
por: Md Khairi, Lukman Nul Hakim, et al.
Publicado: (2022) -
Expert Views on COVAX and Equitable Global Access to COVID-19 Vaccines
por: Manriquez Roa, Tania, et al.
Publicado: (2021) -
COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic
por: Sharun, Khan, et al.
Publicado: (2021)